• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by aTyr Pharma, Inc.

aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
March 13, 2025
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
March 06, 2025
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
March 04, 2025
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
February 24, 2025
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
January 29, 2025
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
December 12, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
December 10, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
December 09, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
November 15, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
November 07, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Present at Upcoming Investor Conferences
October 31, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
October 08, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
October 02, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma to Participate in September Investor Conferences
August 21, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 13, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
July 22, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers ATYR
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
June 03, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 15, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma to Present at Upcoming Investor Conferences
May 06, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Tickers LIFE
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap